Bolt Biotherapeutics, Inc. ( BOLT) - Key Metrics
BOLT Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$4.57 | -$3.87 | -$3.88 |
| 2026Q1 | $0.01 | -$3.87 | -$4.29 | -$4.29 |
| 2025Q4 | $1.34 | -$3.55 | -$3.83 | -$3.83 |
| 2025Q3 | $1.13 | -$3.72 | -$5.07 | -$5.11 |
| 2025Q2 | $0.94 | -$4.46 | -$5 | -$5 |
BOLT Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -0.21 |
| 2026Q1 | 0% | -0.26 |
| 2025Q4 | 0% | -0.36 |
| 2025Q3 | 0% | -0.36 |
| 2025Q2 | 0% | -0.32 |
BOLT
Price: $3.30
52 week price:
Earnings Per Share: -15.77 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 121100
Market Capitalization: 6.2 million